Author:
Watson Brant D.,Sadasivan Chander,Hurst Robert W.
Publisher
Springer International Publishing
Reference59 articles.
1. Adamczyk P, He S, Amar AP, Mack WJ. Medical management of cerebral vasospasm following aneurysmal subarachnoid hemorrhage: a review of current and emerging therapeutic interventions. Neurol Res Int. 2013;2013:462491.
https://doi.org/10.1155/2013/462491
.
2. Andaluz N, Tomsick TA, Tew JM Jr, van Loveren HR, Yeh HS, Zuccarello M. Indications for endovascular therapy for refractory vasospasm after aneurysmal subarachnoid hemorrhage: experience at the University of Cincinnati. Surg Neurol. 2002;58:131–8.
3. Andrews KL, McGuire JJ, Triggle CR. A photosensitive vascular smooth muscle store of nitric oxide in mouse aorta: no dependence on expression of endothelial nitric oxide synthase. Br J Pharmacol. 2003;138:932–40.
https://doi.org/10.1038/sj.bjp.0705115
.
4. Badjatia N, Topcuoglu MA, Pryor JC, Rabinov JD, Ogilvy CS, Carter BS, Rordorf GA. Preliminary experience with intra-arterial nicardipine as a treatment for cerebral vasospasm. AJNR Am J Neuroradiol. 2004;25:819–26.
5. Bauer AM, Rasmussen PA. Treatment of intracranial vasospasm following subarachnoid hemorrhage. Front Neurol. 2014;5:72.
https://doi.org/10.3389/fneur.2014.00072
.